𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Deficiency in DNA mismatch repair increases the rate of telomere shortening in normal human cells

✍ Scribed by Aaron Mendez-Bermudez; Nicola J. Royle


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
339 KB
Volume
32
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

✦ Synopsis


DNA mismatch repair (MMR) is essential for genome stability and inheritance of a mutated MMR gene, most frequently MSH2 or MLH1, results in cancer predisposition known as Lynch syndrome or hereditary nonpolyposis colorectal cancer (HNPCC). Tumors that arise through MMR deficiency show instability at simple tandem repeat loci (STRs) throughout the genome, known as microsatellite instability (MSI). The STR instability is dominated by errors that accumulate during replication in the absence of effective MMR. In this study we show that there is a high level of instability within telomeric DNA with a tendency toward deletions in tumor-derived MMR defective cell lines. We downregulated MSH2 expression in a normal fibroblast cell line and isolated four clones, with differing levels of MSH2 depletion. The telomere-shortening rate was measured at the Xp/Yp, 12q, and 17p telomeres in the MSH2 depleted and three control clones. Interestingly the mean telomere-shortening rate in the clones with MSH2 depletion was significantly greater than in the control clones. This is the first demonstration that MSH2 deficiency alone can lead to accelerated telomere shortening in normal human cells.


πŸ“œ SIMILAR VOLUMES


Increased UV-induced SCEs but normal rep
✍ Kanji Ishizaki; Yosuke Ejima; Tsukasa Matsunaga; Ryujiro Hara; Ayako Sakamoto; M πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 French βš– 442 KB

UV-induced sister chromatid exchanges (SCEs) in p53deficient mouse cells were studied to obtain more evidence regarding the involvement of p53 protein in the DNA repair pathway as a checkpoint protein. After 5 J/m2 UV irradiation, mutant-type homozygous cells for p53-deficiency showed the same numbe

v-src induces cisplatin resistance by in
✍ Naoko Masumoto; Shuji Nakano; Hiromitsu Fujishima; Kimitoshi Kohno; Yoshiyuki Ni πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 133 KB πŸ‘ 1 views

Activation of Src, which has an intrinsic protein tyrosine kinase (PTK) activity, has been demonstrated in human solid tumors, such as colorectal and breast cancers. To investigate the role of activated Src in drug resistance, we evaluated the effect of v-src on the resistance to various anti-cancer